Mucosal immunity to poliovirus.

Abstract

The Global Polio Eradication Initiative (GPEI) currently based on use of oral poliovirus vaccine (OPV) has identified suboptimal immunogenicity of this vaccine as a major impediment to eradication, with a failure to induce protection against paralytic poliomyelitis in certain population segments in some parts of the world. The Mucosal Immunity and Poliovirus Vaccines: Impact on Wild Poliovirus Infection, Transmission and Vaccine Failure conference was organized to obtain a better understanding of the current status of global control of poliomyelitis and identify approaches to improve the immune responsiveness and effectiveness of the orally administered poliovirus vaccines in order to accelerate the global eradication of paralytic poliomyelitis.

• Authors: Pearay L Ogra, Hiromasa Okayasu, Cecil Czerkinsky, Roland W Sutter
• Journal: Expert review of vaccines (Expert Rev Vaccines) Vol. 10 Issue 10 Pg. 1389-92 (Oct 2011) ISSN: 1744-8395 [Electronic] England
• PMID: 21988303 (Publication Type: Congress, Research Support, Non-U.S. Gov't)

Topics

• Humans
• Immunity, Mucosal
• Poliomyelitis (epidemiology, immunology, prevention & control)
• Poliovirus (immunology)